Ordin nr. 1301/500/2008 din 11 iulie 2008 Partea a ii-a

Se aplică tuturor denumirilor comerciale, formelor farmaceutice şi concentraţiilor corespunzătoare DCI-ului.
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

G03GA01 GONADOTROPHINUM LIOF. + SOLV. PT. 5000 ui/ml

CHORIONICUM SOL. INJ.

PREGNYL 5000 5000 ui/ml NV ORGANON

G03GA01 GONADOTROPHINUM LIOF. + SOLV. PT. 500 ui/ml

CHORIONICUM SOL. INJ.

PREGNYL 500 500 ui/ml ORGANON NV

________________________________________________________________________________

______________________________________________________________________________

| 1131 |G03GA02| MENOTROPINUM | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

G03GA02 MENOTROPINUM LIOF. SI SOLV. PT. 75 ui FSH/75 ui LH

SOL. INJ.

MENOGON 75 ui FSH/75 ui LH FERING GMBH

G03GA02 MENOTROPINUM LIOF. + SOLV. PT.

SOL. INJ.

MENOPUR FERRING LAEGEMIDLER A/S

________________________________________________________________________________

______________________________________________________________________________

| 1132 |G04BCN1| COMBINAŢII | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

G04BCN1 COMBINATII GRAN. ORALE

URALYT-U MADAUS GMBH

________________________________________________________________________________

______________________________________________________________________________

| 1133 |H03AA03| COMBINAŢII | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

H03AA03 COMBINATII COMPR. 100 µg + 20 µg

NOVOTHYRAL(R) 100 100 µg + 20 µg MERCK KGAA

________________________________________________________________________________

______________________________________________________________________________

| 1134 |J01CR50| COMBINAŢII | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

J01CR50 COMBINATII PULB. PT. SOL. INJ. 1 g + 1 g

SULPERAZON(R) 2 g 1 g + 1 g PFIZER EUROPE MA EEIG
J01CR50 COMBINATII CAPS. 250 mg + 250 mg

AMPICLOX 250 mg + 250 mg EUROPHARM SA

________________________________________________________________________________
______________________________________________________________________________

| 1135 |J01DB04| CEFAZOLINUM | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

J01DB04 CEFAZOLINUM PULB. PT. SOL. INJ. 1 g

LYZOLIN 1 g MEDICAROM GROUP S.R.L.

________________________________________________________________________________

______________________________________________________________________________

| 1136 |J01DE02| CEFPIROMUM | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

J01DE02 CEFPIROMUM PULB. PT. SOL. 1 g

INJ./PERF.

CEFROM(R) 1 g 1 g LAB. AVENTIS

J01DE02 CEFPIROMUM PULB. PT. SOL.

INJ./PERF. 2 g

CEFROM(R) 2 g 2 g LAB. AVENTIS

________________________________________________________________________________

______________________________________________________________________________

| 1137 |J01EB05| SULFAFURAZOLUM | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

J01EB05 SULFAFURAZOLUM COMPR. 500 mg

NEOXAZOL(R) 500 mg 500 mg ZENTIVA S.A.

SULFAFURAZOL 500 mg ARENA GROUP SA

________________________________________________________________________________
______________________________________________________________________________

| 1138 |J01FA06| ROXITHROMYCINUM | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

J01FA06 ROXITHROMYCINUM COMPR. FILM. 150 mg

ROXAMED(R) 150 150 mg DAR AL DAWA PHARMA S.R.L.

________________________________________________________________________________

______________________________________________________________________________

| 1139 |J01GB03| GENTAMICINUM | |

|_______|_______|____________________________________________|_________________|
Prescriere limitată: Infecţii cu agent patogen sensibil confirmat pentru